This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Behnke, M.
Right arrow Articles by Wobie, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Behnke, M.
Right arrow Articles by Wobie, K.
Related Collections
Right arrow Premature & Newborn

PEDIATRICS Vol. 107 No. 5 May 2001, p. e74

ELECTRONIC ARTICLE:
The Search for Congenital Malformations in Newborns With Fetal Cocaine Exposure

Received Aug 14, 2000; accepted Dec 11, 2000.

Marylou Behnke*, Fonda Davis Eyler*, Cynthia Wilson GarvanDagger , and Kathleen Wobie*

From the * Department of Pediatrics and Dagger  Division of Biostatistics, University of Florida, Gainesville, Florida.

Context.  The association between prenatal cocaine exposure and congenital anomalies is not definitive.

Objective.  To determine whether prenatal cocaine exposure results in an increased number or identifiable pattern of abnormalities.

Design.  A prospective, longitudinal cohort enrolled between 1991 and 1993.

Setting.  Rural public health population delivering at a regional tertiary medical center.

Patients.  Two hundred seventy-two offspring of 154 prenatally identified crack/cocaine users and 154 nonusing controls were matched on race, parity, location of prenatal care (that related to level of pregnancy risk), and socioeconomic status. Drug use was determined through repeated in-depth histories and urine screens. Infants not examined within 7 days of birth were excluded.

Outcome Measures.  Assessments were made by experienced examiners masked to maternal drug history. Included were 16 anthropometric measurements and a checklist of 180 physical features defined and agreed upon in advance.

Results.  There were no differences on major risk variables between the included and excluded infants. There were significantly more premature infants in the cocaine-exposed group. Cocaine-exposed infants were significantly smaller in birth weight, length, and head circumference but did not differ on remaining anthropometric measurements. There was no difference in type or number of abnormalities identified between the exposed and nonexposed groups. There was no relationship between amount or timing of exposure and any of the outcomes.

Conclusions.  This prospective, large-scale, blinded, systematic evaluation for congenital anomalies in prenatally cocaine-exposed children did not identify an increased number or consistent pattern of abnormalities.  Key words:  prenatal cocaine use, pregnancy outcome, congenital anomalies.




This article has been cited by other articles:


Home page
 Evid. Based Nurs.Home page
Other Articles Noted
Evid. Based Nurs., October 1, 2001; 4(4): E1 - 11.
[Full Text] [PDF]